Moffitt Cancer Center Hires New Vice Chair of the Department of Genitourinary Oncology

January 15, 2019

TAMPA, Fla. Manish Kohli, M.D., has joined Moffitt Cancer Center as the vice chair of the Department of Genitourinary Oncology. He also has an extensive research background, focusing on creating new ways to bring individualized care to patients.

“I am honored to be part of a team of world-class cancer experts that apply astounding technological innovation in delivering compassionate care to all cancer patients,” said Kohli.

Kohli comes to Moffitt from the Mayo Clinic, Rochester, where he conducted clinical trials in advanced stages of prostate, kidney, bladder and testicular cancers. He established and oversaw several cancer biorepositories in an effort to identify prognostic and predictive biomarkers and develop molecular diagnostics for genitourinary cancers.

Kohli has also been named the director of the DeBartolo Family Personalized Medicine Institute, Moffitt’s hub for personalized care and research. Created by a generous donation from the DeBartolo Family Foundation in 2012, the institute’s goal is to revolutionize the discovery, delivery and effectiveness of cancer care on an international scale. 

Kohli’s research interests aim to fuse the power of tumor genomics with emerging sciences such as nanotechnology, molecular diagnostics and artificial intelligence tools to determine the most effective treatment strategy and to develop clinical trials. He has obtained multiple federally and privately funded grants, holds multiple patents and has published extensively.

After receiving his medical degree from the University of Delhi, Kohli undertook a residency in Internal Medicine at Cook County Hospital in Chicago and a fellowship in Hematology/Oncology at University of Arkansas for Medical Sciences. In 2015, he received a certification in clinical trials from Harvard Medical School’s Global Clinical Scholars Research Training Program.

About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 49 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt is a Top 10 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt devotes more than 2 million square feet to research and patient care. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 6,000 team members, Moffitt has an economic impact in the state of $2.1 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on FacebookTwitter and YouTube

 

 

###